An out-of-competition doping control that was planned and carried out by the CADF on 31 July 2018 on the Belarusian rider Kanstantsin Siutsou returned an Adverse Analytical Finding (AAF) for Erythropoietin*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.org/inside-uci/press-releases/uci-statement-on-kanstantsin-siutsou). * Erythropoietin is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics (S2)” as per the World Anti-Doping Prohibited List
To find more about the CADF activities in 2017, please read
Aigle, Switzerland, July 4th, 2018 – Today, the Cycling Anti-Doping Foundation (CADF), the independent organisation mandated by the Union Cycliste Internationale (UCI) to define and manage the fight against doping in cycling, announced its strategy for the 2018 Tour de France starting on Saturday 7th July, which will be implemented in close cooperation with the Agence Française de Lutte contre le Dopage (AFLD), the National Anti-Doping Organisation of France.
On 14 June 2018, the CADF Funding Committee met in Geneva and welcomed two new members : Amina Lanaya, Director General of the Union Cycliste Internationale (UCI) and Luc Gheysens, representing the race organisers’ association (AIOCC).
The CADF is delighted to communicate the appointment of Mr. Andy Parkinson as new member of the CADF Foundation Board. Mr. Andy Parkinson is the Chief Executive Officer of British Rowing, having joined the organisation in this role in January 2015.
An intelligence-led doping test was carried out by the CADF in collaboration with the AFLD (Agence Française de Lutte contre le Dopage) and the OCLAEPS (Office Central de Lutte contre les Atteintes à l‘Environnement et la Santé Publique) on March the 8th 2018 on the French Rider Rémy Di Gregorio during the UCI WorldTour race Paris-Nice. The test returned an Adverse Analytical Finding (AAF) for Darbepoetin (dEPO)*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.ch/pressreleases/uci-statement-remy-gregorio/) * dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.”
To Riders and Support Personnel The 2018 Prohibited List comes into effect on 1 January 2018. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)
The CADF Foundation is delighted to announce the appointment of Rune Andersen as Chairman of its Board of directors.
Anti-Doping Norway (ADNO) and the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the Union Cycliste Internationale (UCI) to define and carry out the fight against doping in cycling, are delighted to confirm that they will closely collaborate on anti-doping controls during the 2017 UCI Road World Championships, which begin on 16 September 2017 in Bergen, Norway.
It is with great sadness that we announce the death of Dr George Ruijsch van Dugteren, the CADF President.
Cycling Anti-Doping Foundation
Allée Ferdi Kübler 12
CH 1860 Aigle
Switzerland
